BBC News - Liver cancer drug 'too expensive'A drug that can prolong the lives of patients with advanced liver cancer has been rejected for use in the NHS in England, Wales and Northern Ireland.
The National Institute for Health and Clinical Excellence (NICE) said the cost of Nexavar - about £3,000 a month - was "simply too high".
Professor Peter Littlejohns, clinical and public health director at NICE, said they have to assess the cost-effectiveness of care.
Linkback:
https://tubagbohol.mikeligalig.com/index.php?topic=23911.0